{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:16Z","timestamp":1792785016869,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC No. 82272101"],"award-info":[{"award-number":["NSFC No. 82272101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program of China","award":["No.2018YFE0126500"],"award-info":[{"award-number":["No.2018YFE0126500"]}]},{"name":"the Natural Science Foundation of Shandong Province","award":["No. ZR2021MH060"],"award-info":[{"award-number":["No. ZR2021MH060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07557-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:24:13Z","timestamp":1751401453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiomics reveals metformin\u2019s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuan-dong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-long","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-xiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"1","key":"7557_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73(1), 202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039 (2020).","journal-title":"J. Hepatol."},{"issue":"1","key":"7557_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s2468-1253(20)30294-6","volume":"6","author":"G Shiha","year":"2021","unstructured":"Shiha, G. et al. Redefining fatty liver disease: an international patient perspective. Lancet Gastroenterol. Hepatol. 6(1), 73\u201379. https:\/\/doi.org\/10.1016\/s2468-1253(20)30294-6 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"7557_CR3","doi-asserted-by":"publisher","unstructured":"Bellentani, S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. Off. J. Int. Assoc. Study Liver. 81\u201384. https:\/\/doi.org\/10.1111\/liv.13299 (2017).","DOI":"10.1111\/liv.13299"},{"key":"7557_CR4","doi-asserted-by":"publisher","unstructured":"Zeybel, M. et al. Multiomics analysis reveals the impact of microbiota on host metabolism in hepatic steatosis. Adv. Sci. 9(11), e2104373. https:\/\/doi.org\/10.1002\/advs.202104373 (2022).","DOI":"10.1002\/advs.202104373"},{"issue":"1","key":"7557_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatol. (Baltimore Md). 67(1), 123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466 (2018).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"7557_CR6","doi-asserted-by":"publisher","unstructured":"Cespiati, A. et al. An overview of hepatocellular carcinoma surveillance focusing on non-cirrhotic NAFLD patients: A challenge for physicians. Biomedicines 11(2). https:\/\/doi.org\/10.3390\/biomedicines11020586 (2023).","DOI":"10.3390\/biomedicines11020586"},{"key":"7557_CR7","doi-asserted-by":"publisher","unstructured":"Li, H. et al. Prevalence and risk factors of metabolic associated fatty liver disease in xinxiang, China. Int. J. Environ. Res. Public Health. 17(6). https:\/\/doi.org\/10.3390\/ijerph17061818 (2020).","DOI":"10.3390\/ijerph17061818"},{"issue":"4","key":"7557_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J. Hepatol. 71(4), 793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021 (2019).","journal-title":"J. Hepatol."},{"key":"7557_CR9","doi-asserted-by":"publisher","unstructured":"Lu, Y. et al. Chinese visceral adipose index shows superior diagnostic performance in predicting the risk of metabolic dysfunction associated fatty liver disease in early postmenopausal Chinese women. Diabetes Metab. Syndr. Obes. Targets Ther. 16, 607\u2013617. https:\/\/doi.org\/10.2147\/dmso.S402814 (2023).","DOI":"10.2147\/dmso.S402814"},{"issue":"2","key":"7557_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatol. (Baltimore Md). 51(2), 679\u2013689. https:\/\/doi.org\/10.1002\/hep.23280 (2010).","journal-title":"Hepatol. (Baltimore Md)"},{"issue":"4","key":"7557_CR11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"M Petersen","year":"2018","unstructured":"Petersen, M. & Shulman, G. Mechanisms of insulin action and insulin Resistance. Physiol. Rev. 98(4), 2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017 (2018).","journal-title":"Physiol. Rev."},{"key":"7557_CR12","doi-asserted-by":"publisher","unstructured":"Godoy-Matos, A., Silva J\u00fanior, W. & Valerio, C. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol. Metab. Syndr. 12(60). https:\/\/doi.org\/10.1186\/s13098-020-00570-y (2020).","DOI":"10.1186\/s13098-020-00570-y"},{"issue":"6","key":"7557_CR13","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"M Rinella","year":"2023","unstructured":"Rinella, M. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79(6), 1542\u20131556. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003 (2023).","journal-title":"J. Hepatol."},{"issue":"2","key":"7557_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhep.2020.03.032","volume":"73","author":"C Parisinos","year":"2020","unstructured":"Parisinos, C. et al. Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis. J. Hepatol. 73(2), 241\u2013251. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.032 (2020).","journal-title":"J. Hepatol."},{"issue":"1","key":"7557_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12967-022-03760-6","volume":"21","author":"C Shao","year":"2023","unstructured":"Shao, C. et al. Metabolomics to identify fingerprints of carotid atherosclerosis in Nonobese metabolic dysfunction-associated fatty liver disease. J. Translational Med. 21(1), 12. https:\/\/doi.org\/10.1186\/s12967-022-03760-6 (2023).","journal-title":"J. Translational Med."},{"key":"7557_CR16","doi-asserted-by":"publisher","unstructured":"Heeren, J. & Scheja, L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol. Metabolism. 50, 101238. https:\/\/doi.org\/10.1016\/j.molmet.2021.101238 (2021).","DOI":"10.1016\/j.molmet.2021.101238"},{"key":"7557_CR17","doi-asserted-by":"publisher","unstructured":"Badmus, O. et al. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways. Clin. Sci. 136(18), 1347\u20131366. https:\/\/doi.org\/10.1042\/cs20220572  (2022).","DOI":"10.1042\/cs20220572"},{"issue":"1","key":"7557_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1927633","volume":"13","author":"Y Rao","year":"2021","unstructured":"Rao, Y. et al. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 13(1), 1\u201319. https:\/\/doi.org\/10.1080\/19490976.2021.1927633 (2021).","journal-title":"Gut Microbes"},{"issue":"5","key":"7557_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41591-022-01803-5","volume":"28","author":"W Yang","year":"2022","unstructured":"Yang, W. et al. Dorzagliatin add-on therapy to Metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nat. Med. 28(5), 974\u2013981. https:\/\/doi.org\/10.1038\/s41591-022-01803-5 (2022).","journal-title":"Nat. Med."},{"issue":"6","key":"7557_CR20","doi-asserted-by":"publisher","first-page":"CD012394","DOI":"10.1002\/14651858.CD012394.pub3","volume":"6","author":"R Griffith","year":"2020","unstructured":"Griffith, R. et al. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. Cochrane Database Syst. Rev. 6(6), CD012394. https:\/\/doi.org\/10.1002\/14651858.CD012394.pub3 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"7557_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","volume":"41","author":"L He","year":"2020","unstructured":"He, L. Metformin and systemic metabolism. Trends Pharmacol. Sci. 41(11), 868\u2013881. https:\/\/doi.org\/10.1016\/j.tips.2020.09.001 (2020).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"7557_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/bja\/aer120","volume":"107","author":"G Nicholson","year":"2011","unstructured":"Nicholson, G. & Hall, G. Diabetes mellitus: new drugs for a new epidemic. Br. J. Anaesth. 107(1), 65\u201373. https:\/\/doi.org\/10.1093\/bja\/aer120 (2011).","journal-title":"Br. J. Anaesth."},{"issue":"9","key":"7557_CR23","doi-asserted-by":"publisher","first-page":"e43056","DOI":"10.1371\/journal.pone.0043056","volume":"7","author":"Y Kita","year":"2012","unstructured":"Kita, Y. et al. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PloS One. 7(9), e43056. https:\/\/doi.org\/10.1371\/journal.pone.0043056 (2012).","journal-title":"PloS One"},{"issue":"43","key":"7557_CR24","doi-asserted-by":"publisher","first-page":"e31437","DOI":"10.1097\/md.0000000000031437","volume":"101","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Effect of Metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. Medicine 101(43), e31437. https:\/\/doi.org\/10.1097\/md.0000000000031437 (2022).","journal-title":"Medicine"},{"issue":"1","key":"7557_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41467-019-08585-4","volume":"10","author":"Y Han","year":"2019","unstructured":"Han, Y. et al. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nat. Commun. 10(1), 623. https:\/\/doi.org\/10.1038\/s41467-019-08585-4 (2019).","journal-title":"Nat. Commun."},{"issue":"1","key":"7557_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12974-020-01868-4","volume":"17","author":"S Li","year":"2020","unstructured":"Li, S. et al. Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK\/ACC pathway. J. Neuroinflamm. 17(1), 191. https:\/\/doi.org\/10.1186\/s12974-020-01868-4 (2020).","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"7557_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbcan.2018.11.005","volume":"1871","author":"K Chen","year":"2019","unstructured":"Chen, K. et al. Advancing the understanding of NAFLD to hepatocellular carcinoma development: from experimental models to humans. Biochim. Et Biophys. Acta Reviews cancer. 1871(1), 117\u2013125. https:\/\/doi.org\/10.1016\/j.bbcan.2018.11.005 (2019).","journal-title":"Biochim. Et Biophys. Acta Reviews cancer"},{"issue":"2","key":"7557_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","volume":"73","author":"Y Nevzorova","year":"2020","unstructured":"Nevzorova, Y. et al. Animal models for liver disease - A practical approach for translational research. J. Hepatol. 73(2), 423\u2013440. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.011 (2020).","journal-title":"J. Hepatol."},{"key":"7557_CR29","doi-asserted-by":"publisher","unstructured":"Kanehisa, M., Symposium, N. F. & Kanehisa, M. The KEGG Database. Novartis Found Symp. 28(1), 27\u201330 https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2002).","DOI":"10.1093\/nar\/28.1.27"},{"key":"7557_CR30","doi-asserted-by":"publisher","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 27(1), 29\u201334 https:\/\/doi.org\/10.1093\/nar\/28.1.27 (1999).","DOI":"10.1093\/nar\/28.1.27"},{"issue":"11","key":"7557_CR31","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"K Minoru","year":"2019","unstructured":"Minoru, K. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"7557_CR32","doi-asserted-by":"publisher","unstructured":"Minoru, K. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(0). https:\/\/doi.org\/10.1093\/nar\/gkac963 (2022).","DOI":"10.1093\/nar\/gkac963"},{"issue":"1","key":"7557_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40168-019-0761-z","volume":"7","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Ochratoxin A induces liver inflammation: involvement of intestinal microbiota. Microbiome 7(1), 151. https:\/\/doi.org\/10.1186\/s40168-019-0761-z (2019).","journal-title":"Microbiome"},{"key":"7557_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","volume":"48","author":"I Kirpich","year":"2015","unstructured":"Kirpich, I., Marsano, L. & McClain, C. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin. Biochem. 48, 923\u2013930. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.023 (2015).","journal-title":"Clin. Biochem."},{"issue":"16","key":"7557_CR35","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1111\/bph.14713","volume":"176","author":"Y Rao","year":"2019","unstructured":"Rao, Y. et al. Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease\/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity. Br. J. Pharmacol. 176(16), 2877\u20132893. https:\/\/doi.org\/10.1111\/bph.14713 (2019).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"7557_CR36","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","volume":"10","author":"A Visconti","year":"2019","unstructured":"Visconti, A. et al. Interplay between the human gut microbiome and host metabolism. Nat. Commun. 10(1), 4505. https:\/\/doi.org\/10.1038\/s41467-019-12476-z (2019).","journal-title":"Nat. Commun."},{"issue":"6086","key":"7557_CR37","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"L Hooper","year":"2012","unstructured":"Hooper, L., Littman, D. & Macpherson, A. Interactions between the microbiota and the immune system. Sci. (New York NY). 336(6086), 1268\u20131273. https:\/\/doi.org\/10.1126\/science.1223490 (2012).","journal-title":"Sci. (New York NY)"},{"issue":"1","key":"7557_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40168-019-0720-8","volume":"7","author":"Q Mu","year":"2019","unstructured":"Mu, Q. et al. Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota. Microbiome 7(1), 105. https:\/\/doi.org\/10.1186\/s40168-019-0720-8 (2019).","journal-title":"Microbiome"},{"issue":"1","key":"7557_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 12(1), 1\u201319. https:\/\/doi.org\/10.1080\/19490976.2020.1832857 (2020).","journal-title":"Gut Microbes"},{"issue":"1","key":"7557_CR40","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1038\/s41598-022-20826-z","volume":"12","author":"M Gagn\u00e9","year":"2022","unstructured":"Gagn\u00e9, M. et al. Dysbiotic microbiota contributes to the extent of acute myocardial infarction in rats. Sci. Rep. 12(1), 16517. https:\/\/doi.org\/10.1038\/s41598-022-20826-z (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"7557_CR41","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/13880209.2022.2147551","volume":"60","author":"N Li","year":"2022","unstructured":"Li, N. et al. Cichorium intybusintegration of network Pharmacology and intestinal flora to investigate the mechanism of action of Chinese herbal formula in attenuating adenine and ethambutol hydrochloride-induced hyperuricemic nephropathy in rats. Pharm. Biol. 60(1), 2338\u20132354. https:\/\/doi.org\/10.1080\/13880209.2022.2147551 (2022).","journal-title":"Pharm. Biol."},{"issue":"3","key":"7557_CR42","doi-asserted-by":"publisher","first-page":"e0247378","DOI":"10.1371\/journal.pone.0247378","volume":"16","author":"J Jaimes","year":"2021","unstructured":"Jaimes, J. et al. Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using 1H NMR and 16S rRNA gene profiling. PloS One. 16(3), e0247378. https:\/\/doi.org\/10.1371\/journal.pone.0247378 (2021).","journal-title":"PloS One"},{"issue":"4","key":"7557_CR43","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.18632\/aging.203914","volume":"14","author":"H Yin","year":"2022","unstructured":"Yin, H. et al. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging 14(4), 1941\u20131958. https:\/\/doi.org\/10.18632\/aging.203914 (2022).","journal-title":"Aging"},{"key":"7557_CR44","doi-asserted-by":"publisher","unstructured":"Ermolenko, E. et al. Consortium of indigenous fecal bacteria in the treatment of metabolic syndrome. Microorganisms 10(8). https:\/\/doi.org\/10.3390\/microorganisms10081574 (2022).","DOI":"10.3390\/microorganisms10081574"},{"issue":"2","key":"7557_CR45","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00394-019-01938-1","volume":"59","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice. Eur. J. Nutr. 59(2), 699\u2013718. https:\/\/doi.org\/10.1007\/s00394-019-01938-1 (2020).","journal-title":"Eur. J. Nutr."},{"issue":"5","key":"7557_CR46","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy, S. et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative Colitis. Gastroenterology 156(5), 1440\u20131454e1442. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.001 (2019).","journal-title":"Gastroenterology"},{"key":"7557_CR47","doi-asserted-by":"publisher","unstructured":"Srikanth, E. S. & Shreyas, M. Recent advances, novel targets and treatments for cholelithiasis; a narrative review. Eur. J. Pharmacol. 908, 174376 https:\/\/doi.org\/10.1016\/j.ejphar.2021.174376 (2021).","DOI":"10.1016\/j.ejphar.2021.174376"},{"issue":"1","key":"7557_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/meg.0000000000002456","volume":"35","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. Elevated serum levels of diamine oxidase, D-lactate and lipopolysaccharides are associated with metabolic-associated fatty liver disease. Eur. J. Gastroenterol. Hepatol. 35(1), 94\u2013101. https:\/\/doi.org\/10.1097\/meg.0000000000002456 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"7557_CR49","doi-asserted-by":"publisher","unstructured":"Jia, Q. et al. Fecal microbiota of diarrhea-predominant irritable bowel syndrome patients causes hepatic inflammation of germ-free rats and Berberine reverses it partially. BioMed Res. Int. 2019, 4530203 https:\/\/doi.org\/10.1155\/2019\/4530203 (2019).","DOI":"10.1155\/2019\/4530203"},{"key":"7557_CR50","doi-asserted-by":"publisher","unstructured":"Fuke, N. et al. Regulation of gut microbiota and metabolic endotoxemia with dietary factors. Nutrients 11(10). https:\/\/doi.org\/10.3390\/nu11102277 (2019).","DOI":"10.3390\/nu11102277"},{"issue":"3","key":"7557_CR51","doi-asserted-by":"publisher","first-page":"e0025223","DOI":"10.1128\/msystems.00252-23","volume":"8","author":"F Liu","year":"2023","unstructured":"Liu, F. et al. Age-related alterations in metabolome and microbiome provide insights in dietary transition in giant pandas. mSystems 8(3), e0025223. https:\/\/doi.org\/10.1128\/msystems.00252-23 (2023).","journal-title":"mSystems"},{"issue":"5","key":"7557_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3920\/bm2018.0151","volume":"10","author":"T Culpepper","year":"2019","unstructured":"Culpepper, T. et al. Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study. Beneficial Microbes. 10(5), 497\u2013509. https:\/\/doi.org\/10.3920\/bm2018.0151 (2019).","journal-title":"Beneficial Microbes"},{"issue":"6","key":"7557_CR53","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/liv.14423","volume":"40","author":"C Fuchs","year":"2020","unstructured":"Fuchs, C. et al. Absence of Bsep\/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice. Liver International: Official J. Int. Association Study Liver. 40(6), 1366\u20131377. https:\/\/doi.org\/10.1111\/liv.14423 (2020).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"7557_CR54","doi-asserted-by":"publisher","unstructured":"Prins, G. et al. The effects of butyrate on induced metabolic-associated fatty liver disease in precision-cut liver slices. Nutrients. 13(12). https:\/\/doi.org\/10.3390\/nu13124203 (2021).","DOI":"10.3390\/nu13124203"},{"issue":"4","key":"7557_CR55","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.3892\/etm.2018.6554","volume":"16","author":"T Shen","year":"2018","unstructured":"Shen, T. et al. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1\/AMPK\u03b1 pathway. Experimental Therapeutic Med. 16(4), 3121\u20133128. https:\/\/doi.org\/10.3892\/etm.2018.6554 (2018).","journal-title":"Experimental Therapeutic Med."},{"key":"7557_CR56","doi-asserted-by":"publisher","unstructured":"Ye, J. et al. Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front. Microbiol. 9, 1967. https:\/\/doi.org\/10.3389\/fmicb.2018.01967 (2018).","DOI":"10.3389\/fmicb.2018.01967"},{"issue":"1","key":"7557_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41398-017-0089-z","volume":"8","author":"S Rose","year":"2018","unstructured":"Rose, S. et al. Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Translational Psychiatry. 8(1), 42. https:\/\/doi.org\/10.1038\/s41398-017-0089-z (2018).","journal-title":"Translational Psychiatry"},{"issue":"4","key":"7557_CR58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/db11-0846","volume":"61","author":"H Li","year":"2012","unstructured":"Li, H. et al. Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by Inhibition of histone deacetylase 3. Diabetes 61(4), 797\u2013806. https:\/\/doi.org\/10.2337\/db11-0846 (2012).","journal-title":"Diabetes"},{"key":"7557_CR59","doi-asserted-by":"publisher","unstructured":"Zhang, A. et al. Research progress of metformin in the treatment of liver fibrosis. Int. Immunopharmacol. 116, 109738. https:\/\/doi.org\/10.1016\/j.intimp.2023.109738 (2023).","DOI":"10.1016\/j.intimp.2023.109738"},{"issue":"4","key":"7557_CR60","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/ijmm.2015.2092","volume":"35","author":"A Katsura","year":"2015","unstructured":"Katsura, A. et al. MicroRNA profiles following Metformin treatment in a mouse model of non-alcoholic steatohepatitis. Int. J. Mol. Med. 35(4), 877\u2013884. https:\/\/doi.org\/10.3892\/ijmm.2015.2092 (2015).","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"7557_CR61","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-018-0308-4","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis. Cell Death Dis. 9(3), 264. https:\/\/doi.org\/10.1038\/s41419-018-0308-4 (2018).","journal-title":"Cell Death Dis."},{"key":"7557_CR62","doi-asserted-by":"publisher","unstructured":"Qiao, Y. et al. Single cell derived spheres of umbilical cord mesenchymal stem cells enhance cell stemness properties, survival ability and therapeutic potential on liver failure. Biomaterials 227, 119573. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119573 (2020).","DOI":"10.1016\/j.biomaterials.2019.119573"},{"issue":"1","key":"7557_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41422-021-00565-y","volume":"32","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function. Cell Res. 32(1), 54\u201371. https:\/\/doi.org\/10.1038\/s41422-021-00565-y (2022).","journal-title":"Cell Res."},{"issue":"1","key":"7557_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13046-022-02543-7","volume":"41","author":"D He","year":"2022","unstructured":"He, D. et al. A novel LncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD\u2009+\u2009metabolism and autophagy. J. Experimental Clin. cancer Research: CR. 41(1), 349. https:\/\/doi.org\/10.1186\/s13046-022-02543-7 (2022).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"7557_CR65","doi-asserted-by":"publisher","unstructured":"Alsamman, S. et al. Targeting acid ceramidase inhibits YAP\/TAZ signaling to reduce fibrosis in mice. Sci. Transl. Med. 12, 557. https:\/\/doi.org\/10.1126\/scitranslmed.aay8798 (2020).","DOI":"10.1126\/scitranslmed.aay8798"},{"issue":"1","key":"7557_CR66","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1038\/s41467-019-12351-x","volume":"10","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Inactivation of NF-\u03baB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction. Nat. Commun. 10(1), 4303. https:\/\/doi.org\/10.1038\/s41467-019-12351-x (2019).","journal-title":"Nat. Commun."},{"issue":"1","key":"7557_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-022-01232-3","volume":"8","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation. Signal. Transduct. Target. Therapy. 8(1), 38. https:\/\/doi.org\/10.1038\/s41392-022-01232-3 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"3","key":"7557_CR68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol. 72(3), 558\u2013577. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003 (2020).","journal-title":"J. Hepatol."},{"key":"7557_CR69","doi-asserted-by":"publisher","unstructured":"Liu, N. et al. Auricularia auriculaeffects of polysaccharides on gut microbiota composition in type 2 diabetic mice. Molecules. 27(18). https:\/\/doi.org\/10.3390\/molecules27186061 (2022).","DOI":"10.3390\/molecules27186061"},{"issue":"6","key":"7557_CR70","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1128\/jcm.41.6.2752-2754.2003","volume":"41","author":"E Goldstein","year":"2003","unstructured":"Goldstein, E. et al. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J. Clin. Microbiol. 41(6), 2752\u20132754. https:\/\/doi.org\/10.1128\/jcm.41.6.2752-2754.2003 (2003).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"7557_CR71","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3892\/ijmm.2013.1508","volume":"32","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase\/acetyl-CoA carboxylase pathway in mice. Int. J. Mol. Med. 32(6), 1293\u20131302. https:\/\/doi.org\/10.3892\/ijmm.2013.1508 (2013).","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"7557_CR72","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1463-1326.2005.00497.x","volume":"7","author":"C Bailey","year":"2005","unstructured":"Bailey, C. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones. Diabetes Obes. Metab. 7(6), 675\u2013691. https:\/\/doi.org\/10.1111\/j.1463-1326.2005.00497.x (2005).","journal-title":"Diabetes Obes. Metab."},{"key":"7557_CR73","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Combination of pioglitazone and metformin actions on liver lipid metabolism in obese mice. Biomolecules. 13(8). https:\/\/doi.org\/10.3390\/biom13081199 (2023).","DOI":"10.3390\/biom13081199"},{"key":"7557_CR74","doi-asserted-by":"publisher","unstructured":"He, Z. et al. The roles and mechanisms of LncRNAs in liver fibrosis. Int. J. Mol. Sci. 21(4). https:\/\/doi.org\/10.3390\/ijms21041482 (2020).","DOI":"10.3390\/ijms21041482"},{"key":"7557_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2021.08.001","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform., 19(4), 578\u2013583. https:\/\/doi.org\/10.1016\/j.gpb.2021.08.001. (2021)."},{"key":"7557_CR76","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"Database Resources of the National Genomics Data Center","year":"2022","unstructured":"Database Resources of the National Genomics Data Center. China National Center for bioinformation in 2022. Nucleic Acids Res. 50, D27\u2013D38. https:\/\/doi.org\/10.1093\/nar\/gkab951 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07557-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:24:14Z","timestamp":1751401454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07557-7","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.gpb.2021.08.001","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is to declare that all results and analyses presented in our paper were conducted solely by the authors, without the intervention of Artificial Intelligence (AI) or related technologies. We affirm that the data processing, interpretation, and conclusions drawn in this study were executed manually by the research team, ensuring that the insights and findings reflect our understanding and expertise in the subject matter. We did not employ AI tools or algorithms for data analysis or result generation, thus maintaining the integrity and authenticity of the research. During the preparation of this work the authors used ChatGPT 4.0 in order to improve language and readability. The authors reviewed and edited the content and took full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22699"}}